Biopharma: A Business with Humanity at Its Very Core
The video highlights how biotech capital markets have dramatically tightened over the past three to four years, leaving early‑stage innovators scrambling for funding. With most breakthroughs originating in university labs, scientists often lack the financial acumen to secure capital, prompting reliance on business specialists who can broker partnerships, licensing deals, and other financing mechanisms. As one speaker noted, “when you realize your research could help people, you still need money to move it forward,” underscoring the 15‑20‑year horizon from discovery to market approval. The funding gap threatens the pipeline of new therapies, making investor patience and supportive financing structures essential for sustaining biotech’s humanitarian mission.
What Top Brands Get Right with Tuck's Tami Kim
The video, hosted by Tuck professor Tami Kim, dissects why elite brands consistently outperform competitors. By walking through case studies—from Kylie Cosmetics to Hermès, DuoLingo, the Cheesecake Factory, and Red Bull—Kim illustrates core branding principles that translate across industries. Key insights include...